SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/182616"
 

Search: id:"swepub:oai:gup.ub.gu.se/182616" > Proposal for a "pha...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Proposal for a "phase II" multicenter trial model for preclinical new antiepilepsy therapy development

O'Brien, T. J. (author)
Ben-Menachem, Elinor, 1945 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap och rehabilitering,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Bertram, E. H. (author)
show more...
Collins, S. D. (author)
Kokaia, Merab (author)
Lund University,Lunds universitet,Wallenberg Neurocentrum, Lund,Medicinska fakulteten,Wallenberg Neuroscience Centre, Lund,Faculty of Medicine
Lerche, H. (author)
Klitgaard, H. (author)
Staley, K. J. (author)
Vaudano, E. (author)
Walker, M. C. (author)
Simonato, M. (author)
show less...
 (creator_code:org_t)
2013-08-01
2013
English.
In: Epilepsia. - : Wiley. - 0013-9580. ; 54, s. 70-74
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • There is a pressing need to address the current major gaps in epilepsy treatment, in particular drug-resistant epilepsy, antiepileptogenic therapies, and comorbidities. A major concern in the development of new therapies is that current preclinical testing is not sufficiently predictive for clinical efficacy. Methodologic limitations of current preclinical paradigms may partly account for this discrepancy. Here we propose and discuss a strategy for implementing a "phase II" multicenter preclinical drug trial model based on clinical phase II/III studies designed to generate more rigorous preclinical data for efficacy. The goal is to improve the evidence resulting from preclinical studies for investigational new drugs that have shown strong promise in initial preclinical "phase I" studies. This should reduce the risk for expensive clinical studies in epilepsy and therefore increase the appeal for funders (industry and government) to invest in their clinical development.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Keyword

Preclinical development
Antiepilepsy therapies
Multicenter

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Epilepsia (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view